1. Abuzzahab, F. S. Merwin, G. E., Zimmermann, R. L., Shermann, M. C. (1977): A double blind investigation of piracetam (Nootropil) vs placebo in geriatric memory. Pharmakopsychiat. 10, 49–56.
2. Adolfsson, R., Gottfries, C. G., Oreland, L., Roos, B. E., Winblad, B. (1978): Reduced levels of catecholamines in the brain and increased activity of monoamine oxidase in platelets in Alzheimer’s disease: Therapeutic implications. In: Alzheimer’s Disease: Senile Dementia and Related Disorders. (Katzmann, R., Terry, R. D., Bick, R. R., Hrsg. Aging, Vol. 7.) New York: Raven Press.
3. Arrigo, A., Braun, P., Kautchtschischwilli, G., Moglia, A., Tartara, A., Pavia, L. T. (1973): Influence of treatment of symptomatology and correlated electroencephalographic (EEG) changes in the ages. Curr. ther. Res. 15, 417–426.
4. Baltes, P. B. Baltes, M. M. (1980): Plasticity and variability in psychological aging: methodological and theoretical issues. In: Determining the Effects of Aging on the Central Nervous System (Gurski, G. E., Hrsg.), S. 41–66. Berlin: Schering AG, 1980.
5. Bazo, A. J. (1973): An ergot alkaloid preparation (hydergine) versus papaverine in treating common complaints of the aged: double-blind-study. J. Am. Geriatrics Soc. 22, 63–71.